Atossa Return on Average Equity from 2010 to 2024
| ATOS Stock | USD 1.50 0.01 0.67% |
Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.9 K, Interest Expense of 8.7 K or Selling General Administrative of 13.3 K, as well as many exotic indicators such as Price To Sales Ratio of 7.6 K, Dividend Yield of 0.34 or PTB Ratio of 1.16. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.
Atossa | Return on Average Equity |
About Atossa Genetics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Atossa Genetics income statement, its balance sheet, and the statement of cash flows. Atossa Genetics investors use historical funamental indicators, such as Atossa Genetics's Return on Average Equity, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may use each financial statement separately, they are all related. The changes in Atossa Genetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Atossa Genetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Atossa Genetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Atossa Genetics. Please read more on our technical analysis and fundamental analysis pages.
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. Atossa Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atossa Genetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atossa Genetics' short interest history, or implied volatility extrapolated from Atossa Genetics options trading.
Pair Trading with Atossa Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atossa Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atossa Genetics will appreciate offsetting losses from the drop in the long position's value.Moving together with Atossa Stock
| 0.77 | NXL | Nexalin Technology | PairCorr |
Moving against Atossa Stock
| 0.8 | SINT | SINTX Technologies | PairCorr |
| 0.78 | BBLG | Bone Biologics Corp Financial Report 20th of May 2024 | PairCorr |
| 0.77 | HCAT | Health Catalyst Upward Rally | PairCorr |
| 0.7 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
| 0.68 | PRVA | Privia Health Group Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Atossa Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atossa Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atossa Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atossa Genetics to buy it.
The correlation of Atossa Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atossa Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atossa Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atossa Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Atossa Genetics Correlation against competitors. For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Atossa Stock analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Atossa Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atossa Genetics. If investors know Atossa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atossa Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.24) | Return On Assets (0.18) | Return On Equity (0.29) |
The market value of Atossa Genetics is measured differently than its book value, which is the value of Atossa that is recorded on the company's balance sheet. Investors also form their own opinion of Atossa Genetics' value that differs from its market value or its book value, called intrinsic value, which is Atossa Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atossa Genetics' market value can be influenced by many factors that don't directly affect Atossa Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atossa Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atossa Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atossa Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.